“In Silico Design and Validation of CRISPR-Cas13a System As a Potential Antiviral for SARS-CoV-2 in Indonesia”. Nusantara Science and Technology Proceedings (March 30, 2022): 44–51. Accessed April 24, 2025. https://nstproceeding.com/index.php/nuscientech/article/view/628.